Antibe Therapeutics Inc(Pre-Merger) ATBPF

TSX Interview

[MasterAlgae]

https://www.tsx.com/listings/tsx-and-tsxv-issuer-resources/c-suite-at-the-open?lang=en

• Looking for a strategic exit for Otenaproxesul.
• Likely to uplist to a major exchange which will unlock shareholder value.
• Bring ATB-352 into human trials.

So when they sell Otenaproxesul they will have money to carry on with the other drugs in their pipeline...
The NASDAQ listing will euphemistically "open-up shareholder value."

[crow27]

Something has to give. Only a matter of time folks.

[Forestview]

I averaged down again for some more shares...DON'T LET US DOWN, DAN!  

[MasterAlgae]

I bought more at the open.

[crow27]

We need some players to come in and buy a few million shares here and there. That will just slop up the cheap shares that are being traded back and forth. This can happen at any time, could be today/could be in 2 months. Once the RS is complete then the float is much lower and 5 to 10 million shares traded will make this stock fly. But for now we just keep letting the news flow. One of these NR

[Harper75]

Truthfully, I was hoping for a buyout (been invested since 2015) but I have difficulty seeing a buyout for the entire pipeline with ATB-352 (opiod replacement) looking to go into human trials this year.  The total value of the pipeline with positive early human trials (352) and phase 3 underway for Otenaprox -- can't even hazard a guess.  The prospect of a buyout brings thoughts of